Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P-glycoprotein: a focus on characterizing variability in cardiovascular pharmacotherapeutics.

American journal of therapeutics - 1 Jan 2000

Al-Khazaali Ali, Arora Rohit

Abstract excerpt

According to the report of Agency for Healthcare Research and Quality in 2008, drug-related adverse outcomes exceed 2.7 million events per year. Therefore, it is requisite to understand the etiologies of those unpleasant outcomes. Polypharmacy especially in the elderly is considered one of the ma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Cardiovascular Diseases
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy

Share to Genetic Variation

Share to Membrane Transport Proteins

Share to Pharmaceutical Preparations

Source

Identifiers

PMID: 24401702
DOI: 10.1097/MJT.0000000000000014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24401702-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P-glycoprotein: a focus on characterizing variability in cardiovascular pharmacotherapeutics.PMID 24401702Read ↗

Importance of P‐glycoprotein for drug disposition in humansSemantic proximity Read ↗

[P-glycoprotein--a pump of significance for drug response].Semantic proximity Read ↗

[Pharmacogenomics. What is relevant for the internal medicine specialist?].Semantic proximity Read ↗

Pharmacogenomics of drugs affecting the cardiovascular system.Semantic proximity Read ↗

Future perspectives for the development of P-glycoprotein modulatorsSemantic proximity Read ↗

Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.Semantic proximity Read ↗

[Drug-Drug Interactions with Consideration of Pharmacogenetics].Semantic proximity Read ↗

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.Semantic proximity Read ↗

Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein)Semantic proximity Read ↗

Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.Semantic proximity Read ↗

Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy.Semantic proximity Read ↗

P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.